Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
---|---|---|---|---|---|---|---|---|---|---|---|
ATHA | Athira Pharma, Inc. | CHURCH KEVIN | CHIEF SCIENTIFIC OFFICER | May 18, 2023 | Option Exercise | $2.41 | 809 | 1,950 | 69,271 | Feb 16, 2024, 04:32 PM | |
ATHA | Athira Pharma, Inc. | CHURCH KEVIN | CHIEF SCIENTIFIC OFFICER | Nov 20, 2023 | Option Exercise | $1.34 | 3,397 | 4,552 | 72,668 | Feb 16, 2024, 04:32 PM | |
ATHA | Athira Pharma, Inc. | CHURCH KEVIN | CHIEF SCIENTIFIC OFFICER | Jan 05, 2024 | Sale | $2.91 | 2,412 | 7,019 | 80,256 | Feb 16, 2024, 04:32 PM | |
ATHA | Athira Pharma, Inc. | CHURCH KEVIN | Chief Scientific Officer | May 18, 2023 | Option Exercise | $2.41 | 809 | 1,950 | 69,271 | Jan 08, 2024, 04:36 PM | |
ATHA | Athira Pharma, Inc. | CHURCH KEVIN | Chief Scientific Officer | Nov 20, 2023 | Option Exercise | $1.34 | 3,397 | 4,552 | 72,668 | Jan 08, 2024, 04:36 PM | |
ATHA | Athira Pharma, Inc. | CHURCH KEVIN | Chief Scientific Officer | Jan 05, 2023 | Sale | $2.91 | 2,412 | 7,019 | 80,256 | Jan 08, 2024, 04:36 PM | |
ATHA | Athira Pharma, Inc. | CHURCH KEVIN | Chief Scientific Officer | Mar 24, 2023 | Option Exercise | $1.35 | 6,410 | 8,654 | 68,462 | Mar 27, 2023, 04:57 PM | |
ATHA | Athira Pharma, Inc. | CHURCH KEVIN | Executive VP, Research | Nov 18, 2022 | Option Exercise | $2.74 | 657 | 1,800 | 62,052 | Jan 23, 2023, 05:26 PM | |
ATHA | Athira Pharma, Inc. | CHURCH KEVIN | Executive VP, Research | Oct 28, 2022 | Option Exercise | $1.35 | 3,700 | 4,995 | 61,395 | Oct 31, 2022, 08:17 PM | |
ATHA | Athira Pharma, Inc. | CHURCH KEVIN | Executive VP, Research | Jun 23, 2022 | Sale | $2.69 | 2,614 | 7,032 | 57,695 | Jun 24, 2022, 07:25 PM | |
ATHA | Athira Pharma, Inc. | CHURCH KEVIN | Executive VP, Research | Jun 08, 2022 | Option Exercise | $1.35 | 2,500 | 3,375 | 50,309 | Jun 10, 2022, 05:53 PM | |
ATHA | Athira Pharma, Inc. | CHURCH KEVIN | Executive VP, Research | May 18, 2022 | Option Exercise | $7.06 | 243 | 1,716 | 47,809 | Jun 10, 2022, 05:53 PM | |
ATHA | Athira Pharma, Inc. | CHURCH KEVIN | Executive VP, Research | Feb 18, 2022 | Option Exercise | $1.19 | 3,152 | 3,751 | 47,566 | Feb 18, 2022, 07:38 PM | |
ATHA | Athira Pharma, Inc. | CHURCH KEVIN | Executive VP, Research | Nov 18, 2021 | Option Exercise | $12.51 | 96 | 1,201 | 44,414 | Jan 20, 2022, 05:24 PM | |
ATHA | Athira Pharma, Inc. | CHURCH KEVIN | Vice President of Discovery | May 18, 2021 | Option Exercise | $14.45 | 185 | 2,673 | 41,166 | Jun 10, 2021, 06:41 PM | |
ATHA | Athira Pharma, Inc. | CHURCH KEVIN | Vice President of Discovery | Jun 08, 2021 | Option Exercise | $1.04 | 3,152 | 3,278 | 44,318 | Jun 10, 2021, 06:41 PM |